Literature DB >> 17962622

Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist.

Michelle A Berny1, Tara C White, Erik I Tucker, Leslie A Bush-Pelc, Enrico Di Cera, András Gruber, Owen J T McCarty.   

Abstract

OBJECTIVE: Thrombin containing the mutations Trp215Ala and Glu217Ala (WE) selectively activates protein C and has potent antithrombotic effects in primates. The aim of this study was to delineate the molecular mechanism of direct WE-platelet interactions under static and shear conditions. METHODS AND
RESULTS: Purified platelets under static conditions bound and spread on immobilized wild-type but not WE thrombin. In PPACK-anticoagulated blood under shear flow conditions, platelets tethered and rolled on both wild-type and WE thrombin, and these interactions were abrogated by the presence of a glycoprotein Ib (GPIb)-blocking antibody. Platelet deposition on collagen was blocked in the presence of WE, but not wild-type thrombin or prothrombin. WE also abrogated platelet tethering and rolling on immobilized von Willebrand factor in whole blood under shear flow.
CONCLUSIONS: These observations demonstrate that the thrombin mutant WE, while not activating platelets, retains the ability to interact with platelets through GPIb, and inhibits GPIb-dependent binding to von Willebrand factor-collagen under shear.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962622     DOI: 10.1161/ATVBAHA.107.156273

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  25 in total

1.  WEDGE: an anticoagulant thrombin mutant produced by autoactivation.

Authors:  D C Wood; L A Pelc; N Pozzi; M Wallisch; N G Verbout; E I Tucker; A Gruber; E Di Cera
Journal:  J Thromb Haemost       Date:  2014-11-29       Impact factor: 5.824

2.  Stabilization of the E* form turns thrombin into an anticoagulant.

Authors:  Alaji Bah; Christopher J Carrell; Zhiwei Chen; Prafull S Gandhi; Enrico Di Cera
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

3.  Long range communication between exosites 1 and 2 modulates thrombin function.

Authors:  Nicolas S Petrera; Alan R Stafford; Beverly A Leslie; Colin A Kretz; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

4.  Mechanism of the anticoagulant activity of thrombin mutant W215A/E217A.

Authors:  Prafull S Gandhi; Michael J Page; Zhiwei Chen; Leslie Bush-Pelc; Enrico Di Cera
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

Review 5.  Allostery in trypsin-like proteases suggests new therapeutic strategies.

Authors:  David W Gohara; Enrico Di Cera
Journal:  Trends Biotechnol       Date:  2011-07-02       Impact factor: 19.536

6.  Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2).

Authors:  Tara C White-Adams; Michelle A Berny; Erik I Tucker; Jacqueline M Gertz; David Gailani; Rolf T Urbanus; Philip G de Groot; András Gruber; Owen J T McCarty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-06       Impact factor: 8.311

7.  Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.

Authors:  Madhavi A Jadhav; R Cory Lucas; Whitney N Goldsberry; Muriel C Maurer
Journal:  Biochim Biophys Acta       Date:  2011-07-21

8.  Rigidification of the autolysis loop enhances Na(+) binding to thrombin.

Authors:  Nicola Pozzi; Raymond Chen; Zhiwei Chen; Alaji Bah; Enrico Di Cera
Journal:  Biophys Chem       Date:  2011-04-12       Impact factor: 2.352

9.  Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.

Authors:  Michelle A Berny; Imke C A Munnix; Jocelyn M Auger; Saskia E M Schols; Judith M E M Cosemans; Peter Panizzi; Paul E Bock; Steve P Watson; Owen J T McCarty; Johan W M Heemskerk
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  Characterization of human platelet binding of recombinant T cell receptor ligand.

Authors:  Asako Itakura; Joseph E Aslan; Sushmita Sinha; Tara C White-Adams; Ishan A Patel; Roberto Meza-Romero; Arthur A Vandenbark; Gregory G Burrows; Halina Offner; Owen Jt McCarty
Journal:  J Neuroinflammation       Date:  2010-11-08       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.